Critical review: nicotine for the fetus, the infant and the adolescent?

K H Ginzel1, Gert S Maritz, David F Marks

  • 1khginzel@yahoo.com

Insights

Nicotine Replacement Therapy should not be used by pregnant women or children. Nicotine poses risks including fetotoxicity and neurodevelopmental issues, impacting cognitive and behavioral development in children.

Area of Science:

  • Toxicology
  • Developmental Pediatrics
  • Pharmacology

Background:

  • Nicotine Replacement Therapy (NRT) is increasingly prescribed to pregnant women and children.
  • The physiological impacts of nicotine on developing organisms are not fully considered in NRT expansion.
  • Nicotine is implicated in tobacco-related carcinogenesis.

Purpose of the Study:

  • To highlight the risks of nicotine exposure during pregnancy and childhood.
  • To question the efficacy and safety of NRT in vulnerable populations.
  • To advocate for the avoidance of nicotine in pregnant women, breastfeeding mothers, children, and adolescents.

Main Methods:

  • Review of existing literature on nicotine's physiological effects.
  • Analysis of toxicological and teratogenic data concerning nicotine.
  • Evaluation of NRT efficacy and safety profiles in specific demographics.

Main Results:

  • Nicotine impairs essential physiological functions and is linked to carcinogenesis.
  • Nicotine exhibits fetotoxicity and neuroteratogenicity, leading to developmental disorders.
  • The efficacy of NRT for nicotine addiction is debated, even in adults.

Conclusions:

  • Nicotine poses significant risks to fetal development and the growing organism.
  • Neurodevelopmental, cognitive, affective, and behavioral disorders can result from prenatal nicotine exposure.
  • Nicotine use must be strictly avoided during pregnancy, breastfeeding, childhood, and adolescence due to its detrimental effects.

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...